Purpose:
Airway remodeling is one of the features of severe
asthma. Previous study shows that
IL-27 inhibits airway
inflammation in asthmatic mice. However, the role of
IL-27 on
airway remodeling in OVA-induced asthmatic mice and its possible mechanism remain unclear. Methods: We established an
ovalbumin (OVA)-induced asthmatic mice model.
IL-27 were preventative administered to OVA-induced asthmatic mice. The total cells in Bronchoalveolar lavage fluid (BALF) and
Airway hyperresponsiveness (AHR) were measured. The lung tissues were performed by
Hematoxylin and
eosin (HE) staining to estimate the pathological changes. Masson staining was used to observe the
collagen deposition area. The expression of α-smooth muscle actin (α-SMA) and
Type I collagen was measured by immunohistochemistry, western blot, and quantitative reverse transcription polymerase chain reaction (qRT-PCR). Additionally, western blot was also used to measure the expression of phosphorylated-Akt (p-Akt) in each group. Results:
IL-27 group showed significant inhibitory effect on the α-SMA and
Type I collagen. The expression of p-Akt in the tissues of
asthma model was increased and inhibited by
IL-27. Conclusions:
IL-27 can alleviate
airway remodeling in OVA-induced asthmatic mice, and the mechanism may relate to PI3K/Akt pathway.